Am J Perinatol
DOI: 10.1055/a-2157-3106
Original Article

Risk of Preterm Delivery in Very Advanced Maternal Age Parturients Utilizing In Vitro Fertilization

Rachel A. Newman
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
,
Mariam Naqvi
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
,
Candace Levian
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
,
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
2   Loma Linda University Health, Loma Linda, California
,
Tania Esakoff
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
› Author Affiliations

Abstract

Objective Among patients ≥45 years, the birth rate in the United States continues to increase. As fertility declines with age, this cohort often utilizes assisted reproductive technology, specifically in vitro fertilization (IVF). While both advancing maternal age and IVF are independently associated with adverse maternal outcomes, data regarding their additive effect are scant. This article aims to determine if patients who conceive via IVF are at increased risk for preterm birth (PTB) compared to patients with non-IVF pregnancies in a very advanced maternal age (vAMA) cohort (≥45 years).

Study Design Retrospective cohort study of all pregnant patients ≥45 years old who delivered at a single institution (2014–2021). Those with incomplete delivery/neonatal records or multiples beyond twins were excluded. We compared individuals who conceived via IVF to those who conceived without IVF. The primary outcome was preterm delivery <37 weeks gestation. Secondary outcomes included other adverse perinatal outcomes. Using multivariable logistic regression, we adjusted for multiple gestation as well as confounders found to be significantly different in the univariable analysis and other known risk factors for PTB.

Results In our study cohort of 420 vAMA patients, individuals who underwent IVF were more likely to be older, privately insured, nulliparous, and with a twin gestation. The PTB rate in vAMA patients who underwent IVF was 24.4 compared to 8.4% in patients who did not use IVF (p < 0.001). After adjusting for confounders, IVF was an independent risk factor for PTB <37 weeks in vAMA patients (adjusted odds ratio {aOR] = 4.3, 95% confidence interval [CI]: 1.7–10.4, p = 0.001). In vitro fertilization was also associated with a composite of adverse maternal outcomes (hypertensive disorder of pregnancy, postpartum hemorrhage, blood transfusion, and unplanned hysterectomy) (aOR 1.7, 95% CI [1.1–2.9], p = 0.03).

Conclusion In the vAMA population, conception via IVF is associated with an increased risk of PTB <37 weeks.

Key Points

  • This study examines IVF as an independent risk factor for PTB in patients ≥45 years at delivery, which has not been specifically addressed in prior studies.

  • In vAMA patients, use of IVF is associated with an increased risk of PTB <37 weeks. These patients also have higher rates of cesarean delivery. Neonates from IVF pregnancies are more likely to be very low birth weight or low birth weight.

  • Bodies of research exist for both advanced maternal age and assisted reproductive technology, there is a paucity of data specifically in parturients of vAMA who conceive via IVF.



Publication History

Received: 28 December 2022

Accepted: 17 August 2023

Accepted Manuscript online:
21 August 2023

Article published online:
19 September 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Osterman M, Hamilton B, Martin J, Driscoll A, Valenzuela C. Births: Final Data for 2020. U.S.: National Center for Health Statistics; 2021. DOI: 10.15620/cdc:112078
  • 2 Kenny LC, Lavender T, McNamee R, O'Neill SM, Mills T, Khashan AS. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS ONE 2013; 8 (02) e56583
  • 3 Laopaiboon M, Lumbiganon P, Intarut N. et al; WHO Multicountry Survey on Maternal Newborn Health Research Network. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG 2014; 121 (Suppl. 01) 49-56
  • 4 Hartwig TS, Sørensen S, Jørgensen FS. The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014. Prenat Diagn 2016; 36 (07) 643-649
  • 5 Wong-Taylor LA, Lawrence A, Cowen S. et al. Maternal and neonatal outcomes of spontaneously conceived pregnancies in mothers over 45 years: a review of the literature. Arch Gynecol Obstet 2012; 285 (04) 1161-1166
  • 6 Kort DH, Gosselin J, Choi JM, Thornton MH, Cleary-Goldman J, Sauer MV. Pregnancy after age 50: defining risks for mother and child. Am J Perinatol 2012; 29 (04) 245-250
  • 7 Jackson S, Hong C, Wang ET, Alexander C, Gregory KD, Pisarska MD. Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology. Fertil Steril 2015; 103 (01) 76-80
  • 8 Allen VM, Wilson RD, Cheung A. GENETICS COMMITTEE, REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE. RETIRED: Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006; 28 (03) 220-233
  • 9 Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ 2006; 333 (7570): 679
  • 10 Cavoretto P, Candiani M, Giorgione V. et al. Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF/ICSI treatment: meta-analysis of cohort studies. Ultrasound Obstet Gynecol 2018; 51 (01) 43-53
  • 11 Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004; 328 (7434): 261
  • 12 Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103 (03) 551-563
  • 13 Frick AP. Advanced maternal age and adverse pregnancy outcomes. Best Pract Res Clin Obstet Gynaecol 2021; 70: 92-100
  • 14 Abu-Heija AT, Jallad MF, Abukteish F. Maternal and perinatal outcome of pregnancies after the age of 45. J Obstet Gynaecol Res 2000; 26 (01) 27-30
  • 15 Leader J, Bajwa A, Lanes A. et al. The effect of very advanced maternal age on maternal and neonatal outcomes: a systematic review. J Obstet Gynaecol Can 2018; 40 (09) 1208-1218
  • 16 Wennberg AL, Opdahl S, Bergh C. et al. Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology. Fertil Steril 2016; 106 (05) 1142-1149.e14
  • 17 Malchau SS, Loft A, Larsen EC. et al. Perinatal outcomes in 375 children born after oocyte donation: a Danish national cohort study. Fertil Steril 2013; 99 (06) 1637-1643
  • 18 Dildy GA, Jackson GM, Fowers GK, Oshiro BT, Varner MW, Clark SL. Very advanced maternal age: pregnancy after age 45. Am J Obstet Gynecol 1996; 175 (3 Pt 1): 668-674
  • 19 Laskov I, Birnbaum R, Maslovitz S, Kupferminc M, Lessing J, Many A. Outcome of singleton pregnancy in women ≥ 45 years old: a retrospective cohort study. J Matern Fetal Neonatal Med 2012; 25 (11) 2190-2193